Jacek Pawlak
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Jacek Pawlak has a total of 16 co-authors. Here are the top co-authors by number of shared publications:
- Adam Junka
“PUMA”, Platform for Unique Model Applications, Faculty of Pharmacy, Wroclaw Medical University, Borowska 211, 50-534 Wrocław, Poland
1 shared publication - Casey Chen
Section of Infection and Immunity, Herman Ostrow School of Dentistry, Norris Comprehensive Cancer Center, University of Southern California, Los Angeles, CA 90089, USA
1 shared publication - Charles E. McKenna
Department of Chemistry, University of Southern California, Los Angeles, CA 90089, USA
1 shared publication - Esmat Sodagar
Division of Periodontology, Diagnostic Sciences and Dental Hygiene, Infection and Immunity Laboratory, Herman Ostrow School of Dentistry, University of Southern California, Los Angeles, CA 90007, USA
1 shared publication - Frank Hal Ebetino
Department of Chemistry, University of Rochester, Rochester, NY 14642, USA
1 shared publication - Jeffrey Neighbors
BioVinc LLC, Pasadena, CA 91107, USA
1 shared publication
Latest Publications
- Open Access
- 19 January 2023
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 24 (3) , 1985
Real-Time Impedance-Based Monitoring of the Growth and Inhibition of Osteomyelitis Biofilm Pathogen Staphylococcus aureus Treated with Novel Bisphosphonate-Fluoroquinolone Antimicrobial Conjugates
Osteomyelitis is a limb- and life-threatening orthopedic infection predominantly caused by Staphylococcus aureus biofilms. Bone infections are extremely challenging to treat clinically. Therefore, we have been designing, synthesizing, and testing novel antibiotic conjugates to target bone infections. This class of conjugates comprises bone-binding bisphosphonates as biochemical vectors for the delivery of antibiotic agents to bone minerals (hydroxyapatite). In the present study, we utilized a real-time impedance-based assay to study the growth of Staphylococcus aureus biofilms over time and to test the antimicrobial efficacy of our novel conjugates on the inhibition of biofilm growth in the presence and absence of hydroxyapatite. We tested early and newer generation quinolone antibiotics (ciprofloxacin, moxifloxacin, sitafloxacin, and nemonoxacin) and several bisphosphonate-conjugated versions of these antibiotics (bisphosphonate-carbamate-sitafloxacin (BCS), bisphosphonate-carbamate-nemonoxacin (BCN), etidronate-carbamate-ciprofloxacin (ECC), and etidronate-carbamate-moxifloxacin (ECX)) and found that they were able to inhibit Staphylococcus aureus biofilms in a dose-dependent manner. Among the conjugates, the greatest antimicrobial efficacy was observed for BCN with an MIC of 1.48 µg/mL. The conjugates demonstrated varying antimicrobial activity depending on the specific antibiotic used for conjugation, the type of bisphosphonate moiety, the chemical conjugation scheme, and the presence or absence of hydroxyapatite. The conjugates designed and tested in this study retained the bone-binding properties of the parent bisphosphonate moiety as confirmed using high-performance liquid chromatography. They also retained the antimicrobial activity of the parent antibiotic in the presence or absence of hydroxyapatite, albeit at lower levels due to the nature of their chemical modification. These findings will aid in the optimization and testing of this novel class of drugs for future applications to pharmacotherapy in osteomyelitis.
- 19 January 2023
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 24 (3) , 1985
Open AccessReal-Time Impedance-Based Monitoring of the Growth and Inhibition of Osteomyelitis Biofilm Pathogen Staphylococcus aureus Treated with Novel Bisphosphonate-Fluoroquinolone Antimicrobial Conjugates
Osteomyelitis is a limb- and life-threatening orthopedic infection predominantly caused by Staphylococcus aureus biofilms. Bone infections are extremely challenging to treat clinically. Therefore, we have been designing, synthesizing, and testing novel antibiotic conjugates to target bone infections. This class of conjugates comprises bone-binding bisphosphonates as biochemical vectors for the delivery of antibiotic agents to bone minerals (hydroxyapatite). In the present study, we utilized a real-time impedance-based assay to study the growth of Staphylococcus aureus biofilms over time and to test the antimicrobial efficacy of our novel conjugates on the inhibition of biofilm growth in the presence and absence of hydroxyapatite. We tested early and newer generation quinolone antibiotics (ciprofloxacin, moxifloxacin, sitafloxacin, and nemonoxacin) and several bisphosphonate-conjugated versions of these antibiotics (bisphosphonate-carbamate-sitafloxacin (BCS), bisphosphonate-carbamate-nemonoxacin (BCN), etidronate-carbamate-ciprofloxacin (ECC), and etidronate-carbamate-moxifloxacin (ECX)) and found that they were able to inhibit Staphylococcus aureus biofilms in a dose-dependent manner. Among the conjugates, the greatest antimicrobial efficacy was observed for BCN with an MIC of 1.48 µg/mL. The conjugates demonstrated varying antimicrobial activity depending on the specific antibiotic used for conjugation, the type of bisphosphonate moiety, the chemical conjugation scheme, and the presence or absence of hydroxyapatite. The conjugates designed and tested in this study retained the bone-binding properties of the parent bisphosphonate moiety as confirmed using high-performance liquid chromatography. They also retained the antimicrobial activity of the parent antibiotic in the presence or absence of hydroxyapatite, albeit at lower levels due to the nature of their chemical modification. These findings will aid in the optimization and testing of this novel class of drugs for future applications to pharmacotherapy in osteomyelitis.
- Open Access
- 18 July 2018
- Published by IntechOpen
Hybrid Technique for Incisional Hernias
Hernia is one of the most common complications post any laparotomy. Various techniques are used for the repair of incisional hernias. Hernioplasty with synthetic materials is worldwide standard, and indications to the simple suture methods are rare. Mini-invasive techniques for hernia repair have become popular since 1990 and carry many advantages. Some incisional hernias have a very large hernia sac with large loss of fascia, which makes an exclusive laparoscopic approach challenging. Moreover, some patients are found to have very dense adhesions, which makes laparoscopic approach unsafe, and almost impossible necessitating conversion from laparoscopic to open surgery. Then, the process is carried on until the safe implantation of mesh into abdominal cavity becomes possible. This has led to the birth of what is known as the hybrid technique for incisional hernia repair (laparoscopy, conversion, laparotomy, laparoscopy). Patients with large, complicated, and recurrent incisional hernias should primarily be qualified to hernioplasty with the hybrid technique, which combines the conventional open repairs (safe adhesiolysis, safe placement of laparoscopic tools into the abdominal cavity, closing the defect) with laparoscopic repair (intraperitoneal mesh placing).
- 18 July 2018
- Published by IntechOpen
Open AccessHybrid Technique for Incisional Hernias
Hernia is one of the most common complications post any laparotomy. Various techniques are used for the repair of incisional hernias. Hernioplasty with synthetic materials is worldwide standard, and indications to the simple suture methods are rare. Mini-invasive techniques for hernia repair have become popular since 1990 and carry many advantages. Some incisional hernias have a very large hernia sac with large loss of fascia, which makes an exclusive laparoscopic approach challenging. Moreover, some patients are found to have very dense adhesions, which makes laparoscopic approach unsafe, and almost impossible necessitating conversion from laparoscopic to open surgery. Then, the process is carried on until the safe implantation of mesh into abdominal cavity becomes possible. This has led to the birth of what is known as the hybrid technique for incisional hernia repair (laparoscopy, conversion, laparotomy, laparoscopy). Patients with large, complicated, and recurrent incisional hernias should primarily be qualified to hernioplasty with the hybrid technique, which combines the conventional open repairs (safe adhesiolysis, safe placement of laparoscopic tools into the abdominal cavity, closing the defect) with laparoscopic repair (intraperitoneal mesh placing).
- Open Access
- 1 January 2016
- Published by Index Copernicus in Polish Journal of Surgery
- Vol. 88 (4) , 226-231
Modern Materials Applied in Hernioplasty
- 1 January 2016
- Published by Index Copernicus in Polish Journal of Surgery
- Vol. 88 (4) , 226-231
Open AccessModern Materials Applied in Hernioplasty